US Drug Recall Register
Class II · Moderate risk Terminated Initiated May 16, 2013 (13 years ago)

West-ward Belladonna Alkaloids with Phenobarbital Tablets

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Presence of Foreign Substance: Belladonna Alkaloids with Phenobarbital Tablets with black specks comprised of degraded organic material on tablets.

What was recalled

West-ward Belladonna Alkaloids with Phenobarbital Tablets, a) 1000-count bottle (NDC 0143-1140-10), b) 5000-count bottle (NDC 0143-1140-51), Rx only, Manufactured by West-ward Pharmaceutical Corp., Eatontown, N.J., 07724

Recalling firm
West-Ward Pharmaceutical Corp.
NDC code
0143-1140-10
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-824-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Phenobarbital recalls

See all
Class III · Low risk Terminated

Phenobarbital Elixir

Reason Does Not Meet USP or OTC Monograph: Product exceeds USP specification for alcohol content

Monarch PCM, LLC NDC 69367-172-16 D-0878-2022
Class II · Moderate risk Terminated

PHENOBARBITAL Sodium Injection

Reason Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

Vitae Enim Vitae Scientific, Inc. NDC 42494-416-25 D-0744-2022
Class II · Moderate risk Terminated

PHENOBARBITAL Sodium Injection

Reason Lack of Assurance of Sterility: deviations from Current Good Manufacturing Practices (CGMP) that call into question the sterility of products intended to be sterile.

Vitae Enim Vitae Scientific, Inc. NDC 42494-415-25 D-0743-2022
Class II · Moderate risk Terminated

Phenobarbital Tablets

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. NDC 13517-111-01 D-0470-2021
Class II · Moderate risk Terminated

Phenobarbital Oral Solution

Reason cGMP Deviations: Potential product contamination with Burkholderia cepacia (B.cepacia) and Ralstonia pickettii (R. pickettii).

Torrent Pharma Inc D-1365-2019